Pubblicazioni

Investigational therapies targeting CD3 for prevention and treatment of type 1 diabetes

2021 - EXPERT OPINION ON INVESTIGATIONAL DRUGS

Mignogna, C.; Maddaloni, E.; D'Onofrio, L.; Buzzetti, R.

Linzagolix. a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas

2021 - EXPERT OPINION ON INVESTIGATIONAL DRUGS

Dababou, Susan; Garzon, Simone; LaganÃ , Antonio Simone; Ferrero, Simone; Evangelisti, Giulio; Noventa, Marco; D'Alterio, Maurizio Nicola; Palomba, Stefano; Uccella, Stefano; Franchi, Massimo; Barra, Fabio

Asciminib: an investigational agent for the treatment of chronic myeloid leukemia

2021 - EXPERT OPINION ON INVESTIGATIONAL DRUGS

Breccia, Massimo; Colafigli, Gioia; Scalzulli, Emilia; Martelli, Maurizio